To explore possible LLGL2-interacting molecules that regulate the cytoskeleton in ovarian cancer, we performed immunoprecipitation with a monoclonal antibody specific for LLGL2 and subsequent mass spectrometry analysis to identify possible interacting molecules. Here, LLGL2 is linked to ovarian cancer.